Mikkael Sekeres, MD, MSc
Enriched profileChief, Division of Hematology, and Professor of Medicine with Tenure, Department of Medicine, University of Miami Miller School of Medicine · Sylvester Comprehensive Cancer Center
Mikkael Sekeres is Chief, Division of Hematology, and Professor of Medicine with Tenure, Department of Medicine, University of Miami Miller School of Medicine at Sylvester Comprehensive Cancer Center. OpenAlex indexes 1,453 publications with 37,894 citations (h-index 92); ClinicalTrials.gov lists 10 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Mikkael A. Sekeres, MD, is Chief, Division of Hematology, and Professor of Medicine with Tenure, Department of Medicine, University of Miami Miller School of Medicine at Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Department of Medicine, Division of Hematology. The public record shows 1,453 publications with 37,894 citations (h-index 92), centered on Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 22 companies.
- Most recent indexed publication: 2026 · Leukemia
- Top research focus: Acute Myeloid Leukemia Research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 39 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 401.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Served on the FDA Oncologic Drugs Advisory Committee panel involved in the 2012 decision to withdraw accelerated approval of bevacizumab for breast cancer
and publicly commented on the ethical implications
2012provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newswise.com ↗ - Former Chair
FDA Oncologic Drugs Advisory Committee (ODAC); publicly endorsed FDA approval of imetelstat, testifying "I believe the benefits associated with the drug justify the risks..."
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
Sponsor: Mikkael Sekeres, MD
Industry payments
Updated 27 Aug 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20255 payments
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
90.8%BCL-2 Inhibitor35.1%Venclexta100%Part D≥12 patientsKinase inhibitor29.8%Imatinib Mesylate69%Tasigna31%Part D<11 patientsAnti-infectives
9.2%Fluoroquinolone Antibacterial9.2%Levofloxacin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Quizartinib for patients with newly diagnosed FLT3-ITD-positive AML who received maintenance therapy in QuANTUM-First.
Blood advances
Clinical Trial2026 - Antileukemic therapies for older adults with AML ineligible for conventional therapy: systematic review and meta-analysis.
Blood advances
Meta-analysis2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/mikkael-sekeres-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/mikkael-sekeres-93a648231
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mikkaelsekeres.com/about-me
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mikkaelsekeres.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/sylvestercancer/p/C6rVuu7LGjo
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Facebook
m.facebook.com/SylvesterCancer/videos/meet-dr-mikkael-a-sekeres-dr-sekeres-chief-of-hematology-at-sylvester-explains-h/345427397602383
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →m.facebook.com ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/cancer-stories-the-art-of-oncology/id1365887382
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.umiamihealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- Board Certification: Medical Oncology
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Editorial & leadership roles
journal and society appointments- Chief
Division of Hematology, Department of Medicine, University of Miami Miller School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Professor of Medicine with Tenure
University of Miami Miller School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗ - Chair
ASH Treatment Guidelines for Older Adults with Acute Myeloid Leukemia (AML)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Awards & honors
honors on the public record- Elected Councillor
American Society of Hematology (ASH) Executive Committee, four-year term beginning after the 2025 ASH Annual Meeting
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eurekalert.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Secondary affiliations
appointments beyond the home institution- Former Professor of Medicine
Director of the Leukemia Program, and Vice Chair for Clinical Research, Cleveland Clinic Taussig Cancer Institute
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Physician Liaison in Hematology / co-Chair
Medical Advisory Board, Aplastic Anemia and MDS International Foundation (AAMDSIF), since 2004
2004verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mitpress.mit.edu ↗
- Author of over 100 essays/op-eds in major publications including The New York Times
Wall Street Journal, Washington Post, Slate, and The Hill
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.miami.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jonathan Cohen, MD
Sylvester Comprehensive Cancer Center
Chinmay Jani, MD
Sylvester Comprehensive Cancer Center
Jay Spiegel, MD
Sylvester Comprehensive Cancer Center
Pasquale Benedetto, MD
Sylvester Comprehensive Cancer Center